David Shaw’s Mead Johnson Nutrition Company MJN Stock Holding History

David Shaw’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,000	Closed	-$891K	–	3675
2017 Q1	$891K	Hold	10,000	–	–	﹤0.01%	2371
2016 Q4	$708K	Hold	10,000	–	–	﹤0.01%	2662
2016 Q3	$790K	Hold	10,000	–	–	﹤0.01%	2544
2016 Q2	$908K	Buy	+10,000	New	+$847K	﹤0.01%	2467

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

David Shaw's MJN Position: Q2 2017 in Review

David Shaw sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,009,727 shares — an estimated $89.9M sold.

David Shaw first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $145M in Q1 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

David Shaw reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
David Shaw sold 1,009,727 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $89.9M.
David Shaw first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
David Shaw's Mead Johnson Nutrition Company position peaked at $145M in Q1 2016.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.